Linda Sjöström
Direttore/Membro del Consiglio presso Meabco A/S
Posizioni attive di Linda Sjöström
Società | Posizione | Inizio | Fine |
---|---|---|---|
Meabco A/S
Meabco A/S Pharmaceuticals: MajorHealth Technology Meabco A/S is a privately held oncology Danish biotechnology company established in 2001. Meabco is based in Copenhagen, DK. The company develops breakthrough cancer therapy products to significantly improve life with cancer. The company was founded in 2001 by Stig Løfberg, who has been the CEO since then. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Linda Sjöström
Precedenti posizioni note di Linda Sjöström
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Direttore/Membro del Consiglio | - | 05/07/2011 |
BI Technology A/S
BI Technology A/S Investment ManagersFinance BI Technology A/S (BI-T) is a venture capital firm founded in 1969. The firm is headquartered in Copenhagen, Denmark. | Investitore di Private Equity | 01/01/2001 | 01/02/2009 |
ZEALAND PHARMA A/S | Direttore/Membro del Consiglio | 01/01/2007 | - |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Direttore/Membro del Consiglio | - | - |
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Presidente | - | - |
Statistiche
Distribuzione geografica
Danimarca | 6 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 4 |
Chairman | 1 |
Private Equity Investor | 1 |
Settori
Health Technology | 6 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ZEALAND PHARMA A/S | Health Technology |
Aziende private | 5 |
---|---|
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Health Technology |
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Health Technology |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Health Technology |
BI Technology A/S
BI Technology A/S Investment ManagersFinance BI Technology A/S (BI-T) is a venture capital firm founded in 1969. The firm is headquartered in Copenhagen, Denmark. | Finance |
Meabco A/S
Meabco A/S Pharmaceuticals: MajorHealth Technology Meabco A/S is a privately held oncology Danish biotechnology company established in 2001. Meabco is based in Copenhagen, DK. The company develops breakthrough cancer therapy products to significantly improve life with cancer. The company was founded in 2001 by Stig Løfberg, who has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Linda Sjöström
- Esperienza